Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Artificial intelligence (AI), Fundamental Science, Translational Research, Lymphomas, Genomics, Clinical Research, Bioinformatics, Health disparities research, Diversity, Equity, and Inclusion (DEI), Pediatric, T Cell lymphoma, Diseases, Lymphoid Malignancies, Young adult , Computational biology, Biological Processes, Molecular biology, Technology and Procedures, Study Population, Human, Measurable Residual Disease , Machine learning, Omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Artificial intelligence (AI), Fundamental Science, Translational Research, Lymphomas, Genomics, Clinical Research, Bioinformatics, Health disparities research, Diversity, Equity, and Inclusion (DEI), Pediatric, T Cell lymphoma, Diseases, Lymphoid Malignancies, Young adult , Computational biology, Biological Processes, Molecular biology, Technology and Procedures, Study Population, Human, Measurable Residual Disease , Machine learning, Omics technologies
Saturday, December 7, 2024: 4:00 PM-5:30 PM
Marriott Grand Ballroom 8-9
(Marriott Marquis San Diego Marina)
Moderators:
Caner Saygin, MD, University of Chicago
and
Silvia Bresolin, PhD,
Disclosures:
No relevant conflicts of interest to declare.
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH